Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

With the popularity of AI coding tools rising among some software developers, their adoption has begun to touch every aspect ...

You tell it to clean up a deployment, and it might literally delete a production environment because it doesn’t understand ...

1. Risk: AI Monoculture (Shared Blind Spots). This is the most critical and overlooked systemic vulnerability. Building your ...

Understand flash loan security risks and exploits. Learn how attackers manipulate oracles and governance, and discover best practices for securing DeFi protocols.

Recursion Pharmaceuticals ( RXRX +1.91%) was in the headlines on Monday, and for the right reason. One of the biotech company ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Tennessee is preparing to execute Harold Wayne Nichols by lethal injection for the 1988 rape and murder of 20-year-old Karen ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...

President Trump rated his highly anticipated sit down with Chinese leader Xi Jinping a 12 out of 10. WSJ’s Alexander Ward explains why. Photo: Yonhap/EPA/Shutterstock In an unusual diplomatic move, ...